Basilea to present preclinical brain tumor stem cell data on its oncology drug … – GlobeNewswire (press release)
|
Basilea to present preclinical brain tumor stem cell data on its oncology drug …
GlobeNewswire (press release) BAL27862 stem cell activity, including inhibition of their self-renewal and invasive capacity, was dependent on the expression level of the End-binding 1 protein (EB1), a protein previously shown to be involved in tumor cell migration and overexpressed … |
